Medication Overview

Arava (generic name: leflunomide) is an oral medication used to treat moderate to severe rheumatoid arthritis. It helps reduce symptoms like joint pain, swelling, and stiffness. This drug also helps to slow the progression of the disease and improve physical function. Arava is classified under Disease-Modifying Antirheumatic Drugs (DMARDs).

Active Ingredient

The active ingredient in Arava is leflunomide, which is an immunomodulatory agent that inhibits pyrimidine synthesis, leading to antiproliferative and anti-inflammatory effects. Each Arava tablet contains a specific dosage of leflunomide.

Dosage Forms

Arava is available in tablet form, typically in strengths of 10 mg, 20 mg, and 100 mg. The tablets are usually oval-shaped and may have specific identifying marks to denote their strength. The exact dosage prescribed may vary based on the patient’s health status and severity of symptoms.

Administration Guidelines

Arava tablets should be taken orally, usually once daily, with or without food. Consistent use at the same time each day can help maintain an even level of the medication in your system. Never crush or chew the tablets; swallow them whole with a glass of water.

Initial Loading Dose

In certain cases, an initial loading dose of 100 mg per day for the first three days may be prescribed to rapidly achieve steady-state concentrations. After the loading dose, a maintenance dose is typically introduced. The exact loading dose varies as per individual needs and physician recommendations.

Maintenance Dose

The usual maintenance dose is 20 mg per day, taken continually to manage symptoms. Dosage adjustments might be necessary based on liver function tests and hematologic parameters. For patients experiencing adverse effects, reducing the dose to 10 mg daily may be considered.

Side Effects

Common side effects of Arava may include diarrhea, nausea, hair thinning, and elevated blood pressure. Some patients might experience liver enzyme elevations; hence regular monitoring of liver function tests is crucial. Serious but rare side effects could include severe liver damage, lung disease, and severe allergic reactions.

Monitoring Parameters

Regular monitoring is essential while on Arava. Baseline assessments include liver function tests, a complete blood cell count, and blood pressure measurements. Follow-up tests are generally recommended every 6-8 weeks for the first six months and periodically thereafter.

Drug Interactions

Arava can interact with various other medications, potentially altering its effectiveness or increasing the risk of side effects. Notable interactions include warfarin, methotrexate, and rifampin. Patients should provide a comprehensive list of all medications, including over-the-counter drugs and herbal supplements, to their healthcare provider.

Contraindications

Arava is contraindicated in patients with known hypersensitivity to leflunomide or any of its components. It is also contraindicated in pregnant women or women of childbearing potential who are not using reliable contraception. Chronic liver disease and severe immunodeficiency conditions are additional contraindications.

Hepatotoxicity Risk

Arava carries a risk of hepatotoxicity, which can be severe in some cases. Regular liver function tests are mandatory to detect early signs of liver damage. Patients showing signs of liver dysfunction should discontinue the medication immediately.

Immunosuppressive Effects

As an immunosuppressive agent, Arava can increase the risk of infections. Patients should be vigilant about signs of infection and report them to their healthcare provider promptly. Vaccinations might be less effective during treatment.

Pregnancy Considerations

Arava can cause serious birth defects. Women of childbearing potential should use effective contraception during treatment and for a specified period after discontinuing the drug. Consultation with a healthcare provider is essential if pregnancy is planned or suspected.

Breastfeeding Recommendations

Arava is not recommended for use during breastfeeding as it can pass into breast milk and may harm the nursing infant. Alternatives should be discussed with the healthcare provider.

Alcohol Interaction

Patients taking Arava should avoid alcohol consumption as it increases the risk of liver damage. Even small amounts of alcohol can intensify this risk, hence complete avoidance is advised.

Renal Impairment

The pharmacokinetics of Arava in patients with renal impairment can alter the drug’s excretion, necessitating dosage adjustments. Regular kidney function assessments are recommended during treatment.

Long-term Use

Arava can be used long-term for managing rheumatoid arthritis, provided that regular monitoring is conducted. Periodic assessments help evaluate efficacy and detect potential side effects early. Ongoing communication with healthcare providers is vital.

Discontinuation Protocol

Stopping Arava abruptly without medical advice is not recommended. A washout procedure using cholestyramine or activated charcoal may be required to reduce drug levels rapidly. Follow the specific instructions provided by a healthcare professional for safe discontinuation.

Patient Education

Patients should be informed about the importance of adhering to prescribed dosages and monitoring schedules. They should report any unusual symptoms, particularly signs of liver dysfunction, respiratory issues, or severe skin reactions, to their healthcare provider immediately.

Storage Conditions

Store Arava tablets at room temperature, away from moisture and direct sunlight. Keep the medication out of reach of children and pets. Expired or unused tablets should be disposed of according to proper medical guidelines.

Emergency Situations

In case of overdose, seek immediate medical attention or contact a Poison Control Center. Symptoms of overdose may include diarrhea, abdominal pain, and increased liver enzymes. It is crucial to provide comprehensive patient history and details of the incident to healthcare professionals.

Regular Follow-ups

Regular follow-up appointments with healthcare providers are necessary for adjusting dosages, monitoring the effectiveness, and detecting adverse reactions promptly. Patients should maintain a calendar of their appointments and lab test schedules diligently.

Patient Support

Patients may benefit from additional support services, including educational resources, counseling, and rheumatoid arthritis support groups. Healthcare providers can offer information about these resources to help manage the condition effectively.